U.S. markets open in 8 hours 36 minutes
  • S&P Futures

    4,561.00
    +23.50 (+0.52%)
     
  • Dow Futures

    34,806.00
    +240.00 (+0.69%)
     
  • Nasdaq Futures

    15,746.50
    +28.75 (+0.18%)
     
  • Russell 2000 Futures

    2,185.90
    +26.60 (+1.23%)
     
  • Crude Oil

    67.93
    +1.67 (+2.52%)
     
  • Gold

    1,783.20
    -0.70 (-0.04%)
     
  • Silver

    22.49
    +0.00 (+0.02%)
     
  • EUR/USD

    1.1291
    -0.0027 (-0.24%)
     
  • 10-Yr Bond

    1.3430
    0.0000 (0.00%)
     
  • Vix

    30.67
    +2.72 (+9.73%)
     
  • GBP/USD

    1.3234
    -0.0001 (-0.01%)
     
  • USD/JPY

    113.0430
    +0.2430 (+0.22%)
     
  • BTC-USD

    48,892.97
    -484.63 (-0.98%)
     
  • CMC Crypto 200

    1,256.08
    -185.68 (-12.88%)
     
  • FTSE 100

    7,122.32
    -6.89 (-0.10%)
     
  • Nikkei 225

    27,941.06
    -88.51 (-0.32%)
     

Global Pre-Eclampsia Clinical Trials Market Research Report - ResearchAndMarkets.com

·3 min read

DUBLIN, November 25, 2021--(BUSINESS WIRE)--The "Pre-Eclampsia - Global Clinical Trials Review, H2, 2021" clinical trials has been added to ResearchAndMarkets.com's offering.

This clinical trial report provides an overview of the Pre-Eclampsia Clinical trials scenario. This report provides top line data relating to the clinical trials on Pre-Eclampsia.

Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

  • The report provides a snapshot of the global clinical trials landscape

  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

  • The Report provides enrollment trends for the past five years

  • Report provides latest news for the past three months

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment

  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost

  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

  • Supports understanding of trials count and enrollment trends by country in global therapeutics market

  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Key Topics Covered:

  • Report Guidance

  • The Publisher's Clinical Trials Report Coverage

  • Clinical Trials by Region

  • Clinical Trials and Average Enrollment by Country

  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific

  • Top Five Countries Contributing to Clinical Trials in Europe

  • Top Countries Contributing to Clinical Trials in North America

  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa

  • Top Five Countries Contributing to Clinical Trials in Central and South America

  • Clinical Trials by G7 Countries: Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials

  • Clinical Trials by Phase in G7 Countries

  • Clinical Trials in G7 Countries by Trial Status

  • Clinical Trials by E7 Countries: Proportion of Pre-Eclampsia to Cardiovascular Clinical Trials

  • Clinical Trials by Phase in E7 Countries

  • Clinical Trials in E7 Countries by Trial Status

  • Clinical Trials by Phase

  • In Progress Trials by Phase

  • Clinical Trials by Trial Status

  • Clinical Trials by End Point Status

  • Subjects Recruited Over a Period of Time

  • Clinical Trials by Sponsor Type

  • Prominent Sponsors

  • Top Companies Participating in Pre-Eclampsia Therapeutics Clinical Trials

  • Prominent Drugs

  • Clinical Trial Profile Snapshots

  • Appendix

Companies Mentioned

  • Gynuity Health Projects

  • Wellcome Trust

  • Covis Group Sarl

  • LFB SA

  • Monash Health

  • Novartis AG

  • PerkinElmer Inc

  • Viatris Inc

  • Alexion Pharmaceuticals Inc

  • Bayer AG

For more information about this clinical trials report visit https://www.researchandmarkets.com/r/ixs05v

View source version on businesswire.com: https://www.businesswire.com/news/home/20211125005976/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900